A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction Therapy of T/NK Cell Lymphoma-associated Hemophagocytic Syndrome.
Condition(s):Hemophagocytic Syndrome; T/NK-Cell LymphomaLast Updated:August 11, 2021Recruiting